Menu
GeneBe

rs7759388

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001130700.2(IPCEF1):c.246+49C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.153 in 1,560,458 control chromosomes in the GnomAD database, including 19,767 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (no stars).

Frequency

Genomes: 𝑓 0.14 ( 1603 hom., cov: 31)
Exomes 𝑓: 0.16 ( 18164 hom. )

Consequence

IPCEF1
NM_001130700.2 intron

Scores

2

Clinical Significance

drug response no assertion criteria provided O:1

Conservation

PhyloP100: -0.681
Variant links:
Genes affected
IPCEF1 (HGNC:21204): (interaction protein for cytohesin exchange factors 1) Predicted to enable peroxidase activity. Predicted to be involved in response to oxidative stress. Predicted to be located in cytosol and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
OPRM1 (HGNC:8156): (opioid receptor mu 1) This gene encodes one of at least three opioid receptors in humans; the mu opioid receptor (MOR). The MOR is the principal target of endogenous opioid peptides and opioid analgesic agents such as beta-endorphin and enkephalins. The MOR also has an important role in dependence to other drugs of abuse, such as nicotine, cocaine, and alcohol via its modulation of the dopamine system. The NM_001008503.2:c.118A>G allele has been associated with opioid and alcohol addiction and variations in pain sensitivity but evidence for it having a causal role is conflicting. Multiple transcript variants encoding different isoforms have been found for this gene. Though the canonical MOR belongs to the superfamily of 7-transmembrane-spanning G-protein-coupled receptors some isoforms of this gene have only 6 transmembrane domains. [provided by RefSeq, Oct 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.171 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
IPCEF1NM_001130700.2 linkuse as main transcriptc.246+49C>T intron_variant ENST00000367220.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
IPCEF1ENST00000367220.9 linkuse as main transcriptc.246+49C>T intron_variant 2 NM_001130700.2 A2Q8WWN9-2

Frequencies

GnomAD3 genomes
AF:
0.136
AC:
20687
AN:
152014
Hom.:
1603
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.102
Gnomad AMI
AF:
0.0548
Gnomad AMR
AF:
0.102
Gnomad ASJ
AF:
0.159
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.0640
Gnomad FIN
AF:
0.175
Gnomad MID
AF:
0.146
Gnomad NFE
AF:
0.174
Gnomad OTH
AF:
0.136
GnomAD3 exomes
AF:
0.128
AC:
28384
AN:
221736
Hom.:
2307
AF XY:
0.131
AC XY:
15554
AN XY:
118716
show subpopulations
Gnomad AFR exome
AF:
0.0990
Gnomad AMR exome
AF:
0.0749
Gnomad ASJ exome
AF:
0.154
Gnomad EAS exome
AF:
0.000844
Gnomad SAS exome
AF:
0.0724
Gnomad FIN exome
AF:
0.165
Gnomad NFE exome
AF:
0.174
Gnomad OTH exome
AF:
0.145
GnomAD4 exome
AF:
0.155
AC:
218498
AN:
1408326
Hom.:
18164
Cov.:
29
AF XY:
0.154
AC XY:
107266
AN XY:
696968
show subpopulations
Gnomad4 AFR exome
AF:
0.0952
Gnomad4 AMR exome
AF:
0.0795
Gnomad4 ASJ exome
AF:
0.154
Gnomad4 EAS exome
AF:
0.000763
Gnomad4 SAS exome
AF:
0.0711
Gnomad4 FIN exome
AF:
0.166
Gnomad4 NFE exome
AF:
0.172
Gnomad4 OTH exome
AF:
0.140
GnomAD4 genome
AF:
0.136
AC:
20688
AN:
152132
Hom.:
1603
Cov.:
31
AF XY:
0.132
AC XY:
9849
AN XY:
74370
show subpopulations
Gnomad4 AFR
AF:
0.102
Gnomad4 AMR
AF:
0.102
Gnomad4 ASJ
AF:
0.159
Gnomad4 EAS
AF:
0.000578
Gnomad4 SAS
AF:
0.0636
Gnomad4 FIN
AF:
0.175
Gnomad4 NFE
AF:
0.174
Gnomad4 OTH
AF:
0.136
Alfa
AF:
0.163
Hom.:
4349
Bravo
AF:
0.129
Asia WGS
AF:
0.0310
AC:
109
AN:
3478

ClinVar

Significance: drug response
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Tramadol response Other:1
drug response, no assertion criteria providedresearchBruce Budowle Laboratory, University of North Texas Health Science CenterApr 28, 2018- T:M1 = postmortem ratio or tramadol to O-desmethyltramadol; t-MP = model-based clustered metabolizer phenotype inferred from T:M1

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
Cadd
Benign
3.2
Dann
Benign
0.52

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs7759388; hg19: chr6-154567676; API